Category Archives: Uncategorized
It’s long been known that spiders spiders can “balloon” themselves up into the air using extruded silk strands, sometimes traveling hundreds of miles. Recent work by Erica Morley and Daniel Robert at the University of Bristol demonstrates that the strands … Continue reading
A glimpse into how they made the newest exhibit at the American Museum of Natural History, “Unseen Oceans.” This burger bot makes your lunch with no human help.
Pluto’s moon Charon (technically a binary partner) was first discovered 40 years ago, on June 22, 1978, by U.S. Naval Observatory astronomer James Christy. Like Pluto, it was known only as a blurry smudge until the New Horizons flyby in 2015. … Continue reading
The recent blowout financial results from the FANG companies (Facebook, Amazon, Netflix, Google) reminded me of Marc Andreessen’s bold prediction about software companies. Seems more and more relevant with every passing quarter: 1) Every product or service that can become software … Continue reading
Think about that for a moment. Certainly fits with what most city downtowns are like — swarms of both tourists (rare visitors) and the people who work (or live) there. Empirically the number of visitors scales inversely as the square of … Continue reading
Why Do Gas Station Prices Constantly Change? Blame the Algorithm. Retailers are using artificial-intelligence software to set optimal prices on thousands of items a day, sometimes as often as every hour. Watch This Robot 3D Print a Building Out of Spray Foam. … Continue reading
DESIGNER DRUGS, MICRO ROBOTS, DEEP SPACE MISSIONS. The Origami Revolution. THE OPEN DATA SCIENCE CONFERENCE is coming to Boston on May 3.
Will Knight comments on how the recent Tesla autopilot crash highlights that the increasing complexity of modern AI systems potentially outstrips our ability to comprehend them: Tesla hasn’t disclosed precisely how Autopilot works. But machine learning techniques are increasingly used to train automotive systems, … Continue reading
From BIO (a biotech trade organization), new data shows that over all trials, the 2006-2015 clinical development success rate was only 9.6% for phase I through approval. Some disease areas have had better luck than others, but overall the report is a … Continue reading
Great observations from Arnold Kling, promoting his new ebook, Specialization and Trade: A Re-introduction to Economics. I don’t buy into everything Arnold writes, but I do agree that there are problems with the paradigm of macroeconomists treating the economy like a homogenous GDP factory … Continue reading